US20020066748A1 - Hermetically sealed container with medicament storing and dispensing insert - Google Patents
Hermetically sealed container with medicament storing and dispensing insert Download PDFInfo
- Publication number
- US20020066748A1 US20020066748A1 US09/731,128 US73112800A US2002066748A1 US 20020066748 A1 US20020066748 A1 US 20020066748A1 US 73112800 A US73112800 A US 73112800A US 2002066748 A1 US2002066748 A1 US 2002066748A1
- Authority
- US
- United States
- Prior art keywords
- container
- plunger
- membrane
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 239000012528 membrane Substances 0.000 claims abstract description 36
- 239000007787 solid Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 description 18
- 239000000463 material Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 238000011109 contamination Methods 0.000 description 3
- 239000012815 thermoplastic material Substances 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000012778 molding material Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0046—Cups, bottles or bags
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D1/00—Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
- B65D1/02—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents
- B65D1/0223—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents characterised by shape
- B65D1/023—Neck construction
- B65D1/0238—Integral frangible closures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/24—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
- B65D51/28—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
- B65D51/2807—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container
- B65D51/2814—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it
- B65D51/2828—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it said element being a film or a foil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2027—Separating means having frangible parts
Definitions
- This invention relates to a hermetically sealed container which includes a body filled with a liquid and, more particularly, to an insert for such a container adapted to store and thereafter dispense a medicament such as a tablet into the liquid in the container.
- Hermetically sealed containers can be readily produced by the so-called blow/fill/seal techniques. Utilizing such techniques, a container body is first blow molded from an extruded parison segment, then charged (or filled) with a desired liquid, and thereafter sealed with a preformed closure insert. See, for example, the container structure disclosed in U.S. Pat. No. 4,596,110 to Weiler.
- the liquid in the container body is typically dispensed through the insert and then mixed with another liquid or solid deposit prior to being ingested or otherwise used.
- a disadvantage associated with the mixing of a deposit or the like into the liquid dispensed from the container prior to ingestion or use is the increased risk of contamination inherent in the handling, manipulation and mixing of the deposit such as a tablet or the like in a non-sterile environment.
- a hermetically sealed container of the present invention incorporates a preformed medicament bearing insert assembly adapted and structured to store and thereafter dispense a solid medicament, such as a medicinal tablet or the like, into a liquid contained in the body of the container.
- the insert assembly defines a base member with sealed cavity having a rupturable unitary membrane therewith and a solid medicament contained in the cavity.
- a plunger provided in the insert assembly is adapted to penetrate the membrane so that the medicament can drop into the body of the container when the plunger is activated.
- the plunger can be axially slidable or threaded, as desired.
- the membrane is not completely severed from the base member, however, to dispense the medicament.
- the medicament can be a tablet, a capsule, a pill, an aliquot of a powder, and the like.
- the insert assembly is encapsulated within a hermetically sealed container molded of a thermoplastic material and having a body portion, a neck portion, and an severable overcap unitary therewith.
- the neck portion defines a socket for the insert assembly.
- the severable overcap is delineated from the neck portion by a peripheral frangible web, and protects the insert assembly during storage and handling from premature activation.
- the plunger which is part of the insert assembly, can be activated to release the medicament into the body of the container by urging the plunger against the membrane so as to partially sever the membrane from the insert assembly.
- FIG. 1 is a perspective view of a hermetically sealed container embodying the present invention
- FIG. 2 is an enlarged, partial front elevational view, partially broken away and shows the insert received in a socket provided in the neck portion of the container;
- FIG. 3 is a cross-sectional view of the container socket and insert
- FIG. 4 is a cross-sectional view of the container socket and insert structure where the plunger of the insert assembly has pierced the membrane thereof preparatory to medicament release;
- FIG. 5 is a cross-sectional view of the container socket and insert assembly depicting the plunger in a position where the medicament is released from the insert assembly into the body of the container;
- FIG. 6 is an enlarged, partial front sectional view of an alternate insert assembly embodying the present invention.
- FIG. 7 is a view similar to FIG. 6 and showing a medicament being dispensed
- FIG. 8 is an enlarged, front sectional view of an alternate container embodying the present invention.
- FIG. 9 is an enlarged partial front elevational view, partially broken away, and showing the dispensing nozzle of the container.
- FIG. 10 is a perspective view depicting the container of FIG. 1 in its dispensing position with the overcap and dispensing cap removed therefrom and the medicament in the liquid dissolved in the contents of the container.
- the container of the present invention will be described in a normal (upright) operating position and terms such as upper, lower, horizontal, etc., will be used with reference to this position. It will be understood, however, that the container and the insert assembly of the present invention may be manufactured, stored, transported, used, and sold in an orientation other than the position described.
- FIG. 1 A formed, filled, and hermetically sealed thermoplastic container 10 embodying the insert assembly structure of the present invention is illustrated in FIG. 1.
- Container 10 is preferably fabricated, using a method similar to the method disclosed in U.S. Pat. No. 4,596,110 to Weiler, from conventional molding materials such as polyethylene, polypropylene, and the like, compatible with the contemplated container contents.
- Container 10 is but one example of such a container, inasmuch as a wide variety of container shapes and sizes can be fabricated.
- Container 10 includes a hollow body portion 12 having a bottom portion 14 and a top portion 16 .
- the container body portion 12 is filled with a suitable liquid contents or solution 13 .
- a medicament containing insert assembly 46 is received in a socket 44 provided in a neck portion 38 of the container 10 .
- a severable overcap 48 envelops the upper part of insert assembly 46 .
- the bottom portion 14 of the container 10 terminates in a dispensing nozzle 18 which is in fluid flow communication with the container body portion 12 and the liquid contents 13 therein.
- the container body portion 12 terminates in the neck portion 38 unitary therewith which includes a generally cylindrical throat portion 40 defining a hollow passageway 42 .
- Socket 44 is defined by throat portion 40 and is unitary therewith. Socket 44 is sized to receive the insert assembly 46 .
- Severable overcap 48 envelops insert assembly 46 and is delineated from the socket 44 by a frangible web 49 .
- overcap 48 includes two spaced apart unitary and diametrically opposed grasping wings 50 and 52 to facilitate removal of the overcap 48 when the container 10 is prepared for use.
- Insert assembly 46 is a separately fabricated assembly adapted to be inserted, immobilized and subsequently sealed within the socket 44 of the container 10 using a top insertion method disclosed in, for example, U.S. Pat. No. 4,596,110 to Weiler and U.S. Pat. No. 4,707,966 to Weiler et al.
- the insert assembly 46 may be made of the same type of material as the container 10 , i.e., polyethylene or polypropylene, but can also be molded from a different material such as acrylonitrile-butadiene-styrene (ABS), and the like.
- the insert assembly 46 includes a base member 54 which is immobilized and sealed in the socket 44 of the container 10 .
- the base member 54 defines a medicament pocket 70 and includes first and second collars 56 and 58 , first and second shoulders 60 and 62 and a hollow neck 64 .
- the shoulder 60 extends between the collars 56 and 58 while the shoulder 62 extends between the collar 58 and the neck 64 .
- the base member 54 includes an outer surface 66 and defines a generally cylindrical inner passageway 68 which extends through the collars 56 and 58 and the neck 64 and defines the pocket 70 which terminates in a proximal generally circular aperture 72 occluded by a rupturable membrane 76 .
- Interior face 77 of rupturable membrane 76 seals the interior of the pocket 70 from the container 10 .
- the rupturable membrane 76 is unitary with and is made of the same material as the base member 54 .
- the thickness of the material forming the membrane 76 is selected to provide both good sealing and piercing characteristics.
- Medicament 78 is stored in the pocket 70 and is sealed from the container body 12 by the membrane 76 .
- Medicament 78 can be, for example, a capsule, a tablet, a pill, or an aliquot of powder, as desired.
- the neck 64 of the base member 54 additionally includes a distal flange 80 extending radially outwardly from the outer surface 66 adjacent the distal opening 74 .
- the neck 64 also includes first and second annular ribs 82 and 84 extending outwardly from, and circumferentially around, the outer surface 66 .
- the rib 82 is positioned parallel to, and spaced from, the flange 80 so as to define a groove 86 therebetween.
- the rib 84 is positioned parallel to, and spaced from, the shoulder 62 so as to define a groove or pocket 88 therebetween.
- the insert assembly 46 also includes a plunger 90 movably received in passageway 68 defined in base member 54 .
- Plunger 90 includes a generally cylindrically shaped head unitary with body portion 93 which extends into the passageway 68 of the member 54 .
- the proximal end 94 of plunger 90 has a distal radial end face 96 and an outer surface 98 which abuts and slides against the inner surface of the base member 54 that defines the passageway 68 .
- the solid medicament 78 is stored in the pocket 70 so that it is retained between the end face 96 of the plunger 90 and the membrane 76 .
- the radial end face 96 also can include a pair of spaced-apart prongs 86 and 88 extending outwardly therefrom which define a cradle for the medicament 78 .
- An elongate piercing blade 104 extends from the radial end face 96 outwardly toward the membrane 76 . Outer face 106 of blade 104 slides along passageway 68 of the base member 54 .
- the blade 104 terminates in a pointed tip 108 which is adapted to pierce and partially sever the membrane 76 when the plunger 90 is urged against the membrane 76 .
- Cap 109 of plunger 90 is unitary with the proximal end 94 of plunger body portion 93 and comprises an annular flange 110 which extends radially outwardly from the outer surface 98 of the plunger body portion 93 adjacent the proximal end 94 thereof.
- a circumferential wall 112 depends generally downwardly from the flange 110 .
- the wall 112 is spaced from and generally parallel to the outer surface 98 of the plunger body portion 93 and defines a circumferential hollow sleeve 114 between the wall 112 and the outer surface 98 .
- Annular flange 110 provides a stop as the plunger 90 is urged against the membrane 76 .
- the membrane 76 is not fully severed from the base member 54 when medicament 78 is dispensed so as to keep the membrane 76 from dropping into the container 10 along with the medicament 78 .
- the wall 112 includes an inner surface 116 and a peripheral distal end 118 .
- a finger 120 extends circumferentially and radially inwardly from the inner surface 116 adjacent the peripheral distal end 118 thereof and abuts retaining rib 82 .
- the nozzle 18 at the bottom of container 10 is hollow, generally frustoconical in shape, and at distal end 20 defines an axial dispensing aperture 22 .
- a unitary but removable dispensing cap member 26 is attached to the bottom distal end 20 of the nozzle 18 .
- Dispensing member 26 includes a generally cylindrically shaped twist-off cap 27 including a circumferential lip or edge 28 which is unitary with the lip 24 of the nozzle 18 .
- the lip 24 is delineated from the lip 28 by a circumferential frangible web 30 unitary therewith.
- Dispensing member 26 additionally includes a flat lower base 32 which is unitary with the cap 27 and wings 34 and 36 extending upwardly from opposite ends of the base 32 and on opposite sides of the nozzle 18 in a diametrically opposed relationship.
- the overcap 48 is severed and removed from the container 10 to obtain access to the insert assembly 46 and the plunger 90 thereof. This is achieved by grasping the wings 50 and 52 of the overcap 48 and then exerting a substantially simultaneous twisting and lifting motion to the overcap 48 so as to break the unitary frangible web 49 (FIG. 2) between overcap 48 and container top portion 16 .
- FIG. 3 shows the container 10 with the overcap 48 removed therefrom.
- the plunger 90 of the insert assembly 46 is in its normal upright locked position where the finger 120 on the cap 109 of the plunger 90 is lodged in the pocket 86 defined on the neck 64 of the member 54 between flange 80 and retaining rib 82 .
- FIG. 4 depicts the top of the container 10 and the insert assembly 46 after the plunger 90 has been partially depressed downwardly in the direction of the base member 54 .
- the finger 120 has been dislodged from the pocket 86 and has passed over the rib 82 on the neck 64 into a position where the finger 120 is located between the ribs 82 and 84 on the neck 64 .
- the depression of the plunger 90 also causes the downward movement of the elongate blade 104 extending outwardly from the end of the head 92 which, in turn, causes the tip 108 thereof to contact and pierce the membrane 76 .
- the container 10 at this point can be shaken to allow the composition of the medicament 78 to be thoroughly distributed in the liquid 13 .
- the container 10 then can be turned upside down into a position where the dispensing nozzle 18 faces up and the dispensing member 26 is severed and removed from the nozzle 18 by grasping the wings 34 and 36 thereof and then exerting a simultaneous twisting and lifting motion to break the frangible web 30 .
- the container 10 is then returned to the dispensing position of FIG. 7 for dispensing the liquid mixture.
- FIGS. 6 and 7 depict an alternate insert assembly, generally designated 246 , which includes a plunger 290 with a plunger body portion 293 provided with external threads 295 that engage mating internal threads 297 formed in the base member 254 along the inner surface which defines a central passageway 268 thereof.
- the plunger body portion 293 is urged against the membrane 276 by turning rather than pushing to partially sever the membrane 276 from base member 254 .
- the insert assembly 246 also differs in structure from the insert assembly 46 in that the outer surface 298 of plunger body portion 293 includes a knurled flange portion 299 which extends radially outwardly therefrom adjacent the proximal end 294 and allows the plunger body portion 293 to be easily grasped and turned.
- a second flange portion 301 extends radially outwardly from the outer surface 298 in a parallel and spaced relationship relative to the knurled flange portion 299 .
- the flange portion 301 defines a radial shoulder 303 which, as shown in FIG. 7, is adapted to abut against the shoulder 262 defined at the proximal end 263 of the base member 254 to limit the depth to which the plunger body portion 293 can be threaded into the passageway 268 defined in the base member 254 .
- the membrane 276 differs in structure from the membrane 176 associated with the insert assembly 46 in that the membrane 276 includes a peripheral portion 277 which is thinner than a central portion 279 thereof to further enhance the piercing of the membrane 276 by the tip or edge 208 of the piercing blade 204 which extends downwardly from the distal end face 296 of the plunger body portion 293 .
- the plunger 290 of the insert assembly 246 additionally differs in structure from the plunger 90 of the insert assembly 46 in that the plunger 290 includes an interior cavity 305 which terminates in an opening 307 in the distal end face 296 thereof.
- the opening 307 defines a cradle for the medicament tablet 278 housed in the pocket 270 in a manner similar to the cradle defined by the prongs 86 and 88 of the base member 54 of the insert assembly 46 .
- FIG. 8 depicts yet a further alternate container embodiment 310 including an insert assembly 346 which is similar in structure and function to the insert assembly 246 shown in FIGS. 6 and 7.
- the container embodiment 310 further includes a severable overcap 348 with grasping wings 350 and 351 unitary therewith.
- Overcap 348 is similar in structure to the overcap 48 shown in FIGS. 1 and 2, except that the thermoplastic material forming the overcap 348 also defines a container top portion 422 and stays together with body portion 393 of plunger 390 as body portion 393 is turned. In this particular embodiment, overcap 348 need not be removed in order to activate plunger 390 .
- Flange portions 399 and 401 receive therebetween inwardly extending flange or ring 425 of the material that forms overcap 348 .
- thermoplastic material forming the overcap 348 is brought into intimate and abutting relationship with the outer surface of the plunger 390 and the groove 426 defined therein by flange portions 399 and 401 during the molding of the container 310 and, more particularly, after the insertion and sealing of the insert assembly 346 as is known in the art and shown in U.S. Pat. No. 4,596,110 to Weiler and U.S. Pat. No. 4,707,966 to Weiler et al.
- the overcap 348 is permanently secured to the plunger 390 such that, when the overcap 348 is twisted to break the unitary frangible web 349 , the plunger 390 turns with the overcap 348 .
- the subsequent turning of the overcap 348 causes the downwardly movement of the plunger 390 into piercing and severing contact with the membrane 376 in the same manner as described above with respect to the plunger embodiment 290 to dispense medicament 378 .
- containers including alternate insert assemblies which house and subsequently dispense a medicament into the container body thus eliminating the risk of contamination which can result when medicaments are handled or exposed to non-sterile environments prior to being mixed with a carrier liquid.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Ceramic Engineering (AREA)
- Closures For Containers (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
- This invention relates to a hermetically sealed container which includes a body filled with a liquid and, more particularly, to an insert for such a container adapted to store and thereafter dispense a medicament such as a tablet into the liquid in the container.
- Hermetically sealed containers can be readily produced by the so-called blow/fill/seal techniques. Utilizing such techniques, a container body is first blow molded from an extruded parison segment, then charged (or filled) with a desired liquid, and thereafter sealed with a preformed closure insert. See, for example, the container structure disclosed in U.S. Pat. No. 4,596,110 to Weiler.
- The liquid in the container body is typically dispensed through the insert and then mixed with another liquid or solid deposit prior to being ingested or otherwise used. A disadvantage associated with the mixing of a deposit or the like into the liquid dispensed from the container prior to ingestion or use is the increased risk of contamination inherent in the handling, manipulation and mixing of the deposit such as a tablet or the like in a non-sterile environment.
- There is thus presently a need for a hermetically sealed container where the liquid or solid deposit intended to be mixed with the liquid in the container is stored in the container and mixed with the liquid in the container prior to being dispensed from the container to eliminate the risk of contamination and to simplify the mixing and dispensing procedure.
- A hermetically sealed container of the present invention incorporates a preformed medicament bearing insert assembly adapted and structured to store and thereafter dispense a solid medicament, such as a medicinal tablet or the like, into a liquid contained in the body of the container.
- More particularly, the insert assembly defines a base member with sealed cavity having a rupturable unitary membrane therewith and a solid medicament contained in the cavity. A plunger provided in the insert assembly is adapted to penetrate the membrane so that the medicament can drop into the body of the container when the plunger is activated. The plunger can be axially slidable or threaded, as desired. The membrane is not completely severed from the base member, however, to dispense the medicament.
- The medicament can be a tablet, a capsule, a pill, an aliquot of a powder, and the like.
- The insert assembly is encapsulated within a hermetically sealed container molded of a thermoplastic material and having a body portion, a neck portion, and an severable overcap unitary therewith. The neck portion defines a socket for the insert assembly. The severable overcap is delineated from the neck portion by a peripheral frangible web, and protects the insert assembly during storage and handling from premature activation. When the overcap is removed or severed from the container by a twisting action, the plunger, which is part of the insert assembly, can be activated to release the medicament into the body of the container by urging the plunger against the membrane so as to partially sever the membrane from the insert assembly.
- Other advantages and features of the present invention will be more readily apparent from the following detailed description of the preferred embodiment of the invention, the accompanying drawings, and the appended claims.
- In the Drawings,
- FIG. 1 is a perspective view of a hermetically sealed container embodying the present invention;
- FIG. 2 is an enlarged, partial front elevational view, partially broken away and shows the insert received in a socket provided in the neck portion of the container;
- FIG. 3 is a cross-sectional view of the container socket and insert;
- FIG. 4 is a cross-sectional view of the container socket and insert structure where the plunger of the insert assembly has pierced the membrane thereof preparatory to medicament release;
- FIG. 5 is a cross-sectional view of the container socket and insert assembly depicting the plunger in a position where the medicament is released from the insert assembly into the body of the container;
- FIG. 6 is an enlarged, partial front sectional view of an alternate insert assembly embodying the present invention;
- FIG. 7 is a view similar to FIG. 6 and showing a medicament being dispensed;
- FIG. 8 is an enlarged, front sectional view of an alternate container embodying the present invention;
- FIG. 9 is an enlarged partial front elevational view, partially broken away, and showing the dispensing nozzle of the container; and
- FIG. 10 is a perspective view depicting the container of FIG. 1 in its dispensing position with the overcap and dispensing cap removed therefrom and the medicament in the liquid dissolved in the contents of the container.
- The invention disclosed herein is, of course, susceptible of embodiment in many different forms. Shown in the drawings and described below in detail are preferred embodiments of the container of the present invention. It is to be understood, however, that the present disclosure is an exemplification of the principles of the invention and does not limit the invention to the illustrated embodiments.
- For ease of description, the container of the present invention will be described in a normal (upright) operating position and terms such as upper, lower, horizontal, etc., will be used with reference to this position. It will be understood, however, that the container and the insert assembly of the present invention may be manufactured, stored, transported, used, and sold in an orientation other than the position described.
- A formed, filled, and hermetically sealed
thermoplastic container 10 embodying the insert assembly structure of the present invention is illustrated in FIG. 1.Container 10 is preferably fabricated, using a method similar to the method disclosed in U.S. Pat. No. 4,596,110 to Weiler, from conventional molding materials such as polyethylene, polypropylene, and the like, compatible with the contemplated container contents. -
Container 10 is but one example of such a container, inasmuch as a wide variety of container shapes and sizes can be fabricated.Container 10 includes ahollow body portion 12 having abottom portion 14 and atop portion 16. Thecontainer body portion 12 is filled with a suitable liquid contents orsolution 13. A medicament containinginsert assembly 46 is received in asocket 44 provided in aneck portion 38 of thecontainer 10. Aseverable overcap 48 envelops the upper part ofinsert assembly 46. Thebottom portion 14 of thecontainer 10 terminates in a dispensingnozzle 18 which is in fluid flow communication with thecontainer body portion 12 and theliquid contents 13 therein. - As shown in FIGS. 1, 2 and3, at the
top portion 16, thecontainer body portion 12 terminates in theneck portion 38 unitary therewith which includes a generallycylindrical throat portion 40 defining ahollow passageway 42.Socket 44 is defined bythroat portion 40 and is unitary therewith.Socket 44 is sized to receive theinsert assembly 46. Severable overcap 48 envelops insertassembly 46 and is delineated from thesocket 44 by afrangible web 49. Preferably,overcap 48 includes two spaced apart unitary and diametrically opposedgrasping wings overcap 48 when thecontainer 10 is prepared for use. -
Insert assembly 46 is a separately fabricated assembly adapted to be inserted, immobilized and subsequently sealed within thesocket 44 of thecontainer 10 using a top insertion method disclosed in, for example, U.S. Pat. No. 4,596,110 to Weiler and U.S. Pat. No. 4,707,966 to Weiler et al. Theinsert assembly 46 may be made of the same type of material as thecontainer 10, i.e., polyethylene or polypropylene, but can also be molded from a different material such as acrylonitrile-butadiene-styrene (ABS), and the like. - Referring to FIGS. 2 and 3, the
insert assembly 46 includes abase member 54 which is immobilized and sealed in thesocket 44 of thecontainer 10. Thebase member 54 defines amedicament pocket 70 and includes first andsecond collars second shoulders hollow neck 64. Theshoulder 60 extends between thecollars shoulder 62 extends between thecollar 58 and theneck 64. Thebase member 54 includes an outer surface 66 and defines a generally cylindricalinner passageway 68 which extends through thecollars neck 64 and defines thepocket 70 which terminates in a proximal generallycircular aperture 72 occluded by arupturable membrane 76. -
Interior face 77 ofrupturable membrane 76 seals the interior of thepocket 70 from thecontainer 10. Therupturable membrane 76 is unitary with and is made of the same material as thebase member 54. The thickness of the material forming themembrane 76 is selected to provide both good sealing and piercing characteristics. -
Medicament 78 is stored in thepocket 70 and is sealed from thecontainer body 12 by themembrane 76.Medicament 78 can be, for example, a capsule, a tablet, a pill, or an aliquot of powder, as desired. - The
neck 64 of thebase member 54 additionally includes adistal flange 80 extending radially outwardly from the outer surface 66 adjacent thedistal opening 74. Theneck 64 also includes first and secondannular ribs rib 82 is positioned parallel to, and spaced from, theflange 80 so as to define agroove 86 therebetween. Therib 84 is positioned parallel to, and spaced from, theshoulder 62 so as to define a groove orpocket 88 therebetween. - The
insert assembly 46 also includes aplunger 90 movably received inpassageway 68 defined inbase member 54.Plunger 90 includes a generally cylindrically shaped head unitary withbody portion 93 which extends into thepassageway 68 of themember 54. Theproximal end 94 ofplunger 90 has a distalradial end face 96 and anouter surface 98 which abuts and slides against the inner surface of thebase member 54 that defines thepassageway 68. - The
solid medicament 78 is stored in thepocket 70 so that it is retained between theend face 96 of theplunger 90 and themembrane 76. Theradial end face 96 also can include a pair of spaced-apartprongs medicament 78. An elongate piercingblade 104 extends from the radial end face 96 outwardly toward themembrane 76. Outer face 106 ofblade 104 slides alongpassageway 68 of thebase member 54. Theblade 104 terminates in apointed tip 108 which is adapted to pierce and partially sever themembrane 76 when theplunger 90 is urged against themembrane 76. -
Cap 109 ofplunger 90 is unitary with theproximal end 94 ofplunger body portion 93 and comprises an annular flange 110 which extends radially outwardly from theouter surface 98 of theplunger body portion 93 adjacent theproximal end 94 thereof. Acircumferential wall 112 depends generally downwardly from the flange 110. Thewall 112 is spaced from and generally parallel to theouter surface 98 of theplunger body portion 93 and defines a circumferentialhollow sleeve 114 between thewall 112 and theouter surface 98. Annular flange 110 provides a stop as theplunger 90 is urged against themembrane 76. Themembrane 76 is not fully severed from thebase member 54 whenmedicament 78 is dispensed so as to keep themembrane 76 from dropping into thecontainer 10 along with themedicament 78. - The
wall 112 includes aninner surface 116 and a peripheraldistal end 118. Afinger 120 extends circumferentially and radially inwardly from theinner surface 116 adjacent the peripheraldistal end 118 thereof and abuts retainingrib 82. - As shown in FIGS. 1, 9 and10, the
nozzle 18 at the bottom ofcontainer 10 is hollow, generally frustoconical in shape, and at distal end 20 defines anaxial dispensing aperture 22. A unitary but removabledispensing cap member 26 is attached to the bottom distal end 20 of thenozzle 18. Dispensingmember 26 includes a generally cylindrically shaped twist-off cap 27 including a circumferential lip or edge 28 which is unitary with thelip 24 of thenozzle 18. Thelip 24 is delineated from thelip 28 by a circumferentialfrangible web 30 unitary therewith. - Dispensing
member 26 additionally includes a flatlower base 32 which is unitary with thecap 27 andwings base 32 and on opposite sides of thenozzle 18 in a diametrically opposed relationship. - The use and operation of the
container 10 and theinsert assembly 46 thereof for storing, dispensing and thereafter mixing themedication 78 with a liquid 13 in thecontainer body 12 will now be described with reference to FIGS. 2-5, 9 and 10. - Initially, the
overcap 48 is severed and removed from thecontainer 10 to obtain access to theinsert assembly 46 and theplunger 90 thereof. This is achieved by grasping thewings overcap 48 and then exerting a substantially simultaneous twisting and lifting motion to theovercap 48 so as to break the unitary frangible web 49 (FIG. 2) betweenovercap 48 andcontainer top portion 16. - FIG. 3 shows the
container 10 with theovercap 48 removed therefrom. Theplunger 90 of theinsert assembly 46 is in its normal upright locked position where thefinger 120 on thecap 109 of theplunger 90 is lodged in thepocket 86 defined on theneck 64 of themember 54 betweenflange 80 and retainingrib 82. - FIG. 4 depicts the top of the
container 10 and theinsert assembly 46 after theplunger 90 has been partially depressed downwardly in the direction of thebase member 54. Thefinger 120 has been dislodged from thepocket 86 and has passed over therib 82 on theneck 64 into a position where thefinger 120 is located between theribs neck 64. The depression of theplunger 90 also causes the downward movement of theelongate blade 104 extending outwardly from the end of the head 92 which, in turn, causes thetip 108 thereof to contact and pierce themembrane 76. - The continued downward axial movement of the
plunger 90 in the direction of thebase member 54 into the position of FIG. 5 where thefinger 120 of theplunger 90 is lodged in thepocket 88 on theneck 64 of thebase member 54 causes the further downward movement of theplunger body portion 93 through thepocket 70 which, in turn, causes themedicament 78 to be pushed out of thepocket 70 through the nowopen aperture 72 in thebase member 54 and into thecontainer body 12 where themedicament 78 is dissolved and mixed in the liquid 13. The pierced membrane remains with thebase member 54, however. - The
container 10 at this point can be shaken to allow the composition of themedicament 78 to be thoroughly distributed in the liquid 13. Thecontainer 10 then can be turned upside down into a position where the dispensingnozzle 18 faces up and the dispensingmember 26 is severed and removed from thenozzle 18 by grasping thewings frangible web 30. Thecontainer 10 is then returned to the dispensing position of FIG. 7 for dispensing the liquid mixture. - FIGS. 6 and 7 depict an alternate insert assembly, generally designated246, which includes a
plunger 290 with aplunger body portion 293 provided withexternal threads 295 that engage matinginternal threads 297 formed in thebase member 254 along the inner surface which defines acentral passageway 268 thereof. In such a case, theplunger body portion 293 is urged against themembrane 276 by turning rather than pushing to partially sever themembrane 276 frombase member 254. - The
insert assembly 246 also differs in structure from theinsert assembly 46 in that theouter surface 298 ofplunger body portion 293 includes aknurled flange portion 299 which extends radially outwardly therefrom adjacent theproximal end 294 and allows theplunger body portion 293 to be easily grasped and turned. - A
second flange portion 301 extends radially outwardly from theouter surface 298 in a parallel and spaced relationship relative to theknurled flange portion 299. Theflange portion 301 defines aradial shoulder 303 which, as shown in FIG. 7, is adapted to abut against theshoulder 262 defined at theproximal end 263 of thebase member 254 to limit the depth to which theplunger body portion 293 can be threaded into thepassageway 268 defined in thebase member 254. - The
membrane 276 differs in structure from the membrane 176 associated with theinsert assembly 46 in that themembrane 276 includes aperipheral portion 277 which is thinner than acentral portion 279 thereof to further enhance the piercing of themembrane 276 by the tip or edge 208 of the piercingblade 204 which extends downwardly from thedistal end face 296 of theplunger body portion 293. - The
plunger 290 of theinsert assembly 246 additionally differs in structure from theplunger 90 of theinsert assembly 46 in that theplunger 290 includes aninterior cavity 305 which terminates in anopening 307 in thedistal end face 296 thereof. Theopening 307 defines a cradle for themedicament tablet 278 housed in the pocket 270 in a manner similar to the cradle defined by theprongs base member 54 of theinsert assembly 46. - The other elements and features of the
alternate insert assembly 246 are similar to the elements and features of theinsert assembly 46. - FIG. 8 depicts yet a further
alternate container embodiment 310 including aninsert assembly 346 which is similar in structure and function to theinsert assembly 246 shown in FIGS. 6 and 7. Thecontainer embodiment 310 further includes aseverable overcap 348 with graspingwings 350 and 351 unitary therewith.Overcap 348 is similar in structure to theovercap 48 shown in FIGS. 1 and 2, except that the thermoplastic material forming theovercap 348 also defines acontainer top portion 422 and stays together withbody portion 393 ofplunger 390 asbody portion 393 is turned. In this particular embodiment,overcap 348 need not be removed in order to activateplunger 390.Flange portions ring 425 of the material that formsovercap 348. - The thermoplastic material forming the
overcap 348 is brought into intimate and abutting relationship with the outer surface of theplunger 390 and thegroove 426 defined therein byflange portions container 310 and, more particularly, after the insertion and sealing of theinsert assembly 346 as is known in the art and shown in U.S. Pat. No. 4,596,110 to Weiler and U.S. Pat. No. 4,707,966 to Weiler et al. - As a result, the
overcap 348 is permanently secured to theplunger 390 such that, when theovercap 348 is twisted to break the unitaryfrangible web 349, theplunger 390 turns with theovercap 348. The subsequent turning of theovercap 348, in turn, causes the downwardly movement of theplunger 390 into piercing and severing contact with themembrane 376 in the same manner as described above with respect to theplunger embodiment 290 to dispensemedicament 378. - What has thus been disclosed and described are containers including alternate insert assemblies which house and subsequently dispense a medicament into the container body thus eliminating the risk of contamination which can result when medicaments are handled or exposed to non-sterile environments prior to being mixed with a carrier liquid.
Claims (5)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/731,128 US6387073B1 (en) | 2000-12-06 | 2000-12-06 | Hermetically sealed container with medicament storing and dispensing insert |
CA002430715A CA2430715C (en) | 2000-12-06 | 2001-12-04 | Hermetically sealed container with medicament storing and dispensing insert |
AT01989899T ATE439824T1 (en) | 2000-12-06 | 2001-12-04 | CONTAINER WITH INSERT FOR STORING AND DISPENSING MEDICATIONS |
DE60139637T DE60139637D1 (en) | 2000-12-06 | 2001-12-04 | CONTAINER WITH INPUT FOR STORING AND DISTRIBUTING MEDICAMENTS |
MXPA03005089A MXPA03005089A (en) | 2000-12-06 | 2001-12-04 | Container with medicamentstoring and dispensing insert. |
PCT/US2001/046384 WO2002045789A1 (en) | 2000-12-06 | 2001-12-04 | Container with medicamentstoring and dispensing insert |
JP2002547569A JP2004515279A (en) | 2000-12-06 | 2001-12-04 | Closed container with insert for storing and delivering medication |
EP01989899A EP1345647B1 (en) | 2000-12-06 | 2001-12-04 | Container with medicament storing and dispensing insert |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/731,128 US6387073B1 (en) | 2000-12-06 | 2000-12-06 | Hermetically sealed container with medicament storing and dispensing insert |
Publications (2)
Publication Number | Publication Date |
---|---|
US6387073B1 US6387073B1 (en) | 2002-05-14 |
US20020066748A1 true US20020066748A1 (en) | 2002-06-06 |
Family
ID=24938182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/731,128 Expired - Lifetime US6387073B1 (en) | 2000-12-06 | 2000-12-06 | Hermetically sealed container with medicament storing and dispensing insert |
Country Status (8)
Country | Link |
---|---|
US (1) | US6387073B1 (en) |
EP (1) | EP1345647B1 (en) |
JP (1) | JP2004515279A (en) |
AT (1) | ATE439824T1 (en) |
CA (1) | CA2430715C (en) |
DE (1) | DE60139637D1 (en) |
MX (1) | MXPA03005089A (en) |
WO (1) | WO2002045789A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060057257A1 (en) * | 2003-10-27 | 2006-03-16 | Ma Mike X | Twist-open closure having inclined frangible membrane |
US20060108314A1 (en) * | 2004-11-23 | 2006-05-25 | Cho Young K | Sanitary double cap allowing addition of adjunct to contents of a container |
US20070262045A1 (en) * | 2004-11-08 | 2007-11-15 | Bernd Hansen | Container, in Particular an Ampoule |
US20110000800A1 (en) * | 2009-02-11 | 2011-01-06 | Robert Dale Rohr | Inverted dome to supply dose |
US20110054437A1 (en) * | 2008-04-17 | 2011-03-03 | Philippe Perovitch | Device for conserving, extemporaneously preparing, and administering an active principle |
WO2012052853A3 (en) * | 2010-10-21 | 2012-11-01 | Aptalis Pharma Limited | Oral dosing device for administration of medication |
KR101403015B1 (en) | 2012-02-29 | 2014-06-03 | 주식회사태준제약 | Dispensing container |
US10293993B2 (en) | 2009-11-05 | 2019-05-21 | Liquid Health Labs, Inc. | Universal domed closure to supply dose |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10007581C2 (en) * | 2000-02-21 | 2003-05-28 | 3M Espe Ag | Mixing capsule, process for its production and its use |
US20050019272A1 (en) * | 2003-07-24 | 2005-01-27 | Harrison Johnnie Mae | Portable mouth wash system |
KR100593245B1 (en) * | 2003-12-30 | 2006-06-28 | 조영국 | bottle cap assembly for simultaneously dissolve additives |
US20050167297A1 (en) * | 2004-01-30 | 2005-08-04 | Emanuel Shenkar | Easy-open closure for container and method of use |
US20050167296A1 (en) * | 2004-01-30 | 2005-08-04 | Emanuel Shenkar | Dosing closure and method of using |
US20050167295A1 (en) * | 2004-01-30 | 2005-08-04 | Emanuel Shenkar | Portion closure and method of using |
US8215481B1 (en) * | 2004-02-18 | 2012-07-10 | Knickerbocker Michael G | Container closure for retaining an additive material |
JP5127456B2 (en) * | 2004-11-04 | 2013-01-23 | ヴィズ エンタープライゼズ,エルエルシー | Multi-chamber container and its lid |
US20080156674A1 (en) * | 2006-11-09 | 2008-07-03 | Puricore, Inc. | Apparatuses and systems for storing, dispensing, and reconstituting materials |
US8276748B2 (en) * | 2007-03-16 | 2012-10-02 | The Coca-Cola Company | Ingredient release spout |
US8443969B2 (en) * | 2007-03-16 | 2013-05-21 | The Coca-Cola Company | Ingredient release spout |
US9592940B2 (en) * | 2007-03-16 | 2017-03-14 | The Coca-Cola Company | Ingredient release spout |
PE20090099A1 (en) * | 2007-03-30 | 2009-02-13 | Schering Corp | MULTIPLE COMPARTMENT PACKAGING |
FR2922867B1 (en) * | 2007-10-31 | 2009-12-25 | Idecap | DOSING DEVICE ADAPTABLE ON A CONTAINER |
US7874420B2 (en) | 2009-02-09 | 2011-01-25 | Darren Coon | Affixable dispensing capsule |
US9067716B2 (en) | 2011-09-30 | 2015-06-30 | Federico Intriago | Cap assembly for dispensing a dispensable component and method of making and using the same |
EP3077031B1 (en) * | 2013-12-04 | 2020-11-25 | Hollister Incorporated | Urinary catheter protective tips having a fluid reservoir |
GB201415869D0 (en) * | 2014-09-08 | 2014-10-22 | Eulysis Uk Ltd | Container And Closure |
ITUA20162141A1 (en) * | 2016-03-31 | 2017-10-01 | Bormioli Pharma Spa | CLOSING CAPS |
US11834239B2 (en) * | 2021-03-04 | 2023-12-05 | Psimos, Inc. | Reusable dispenser lid |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2773591A (en) | 1952-10-22 | 1956-12-11 | Novo Terapeutisk Labor As | Vessel with sterile closure for separate storage of at least two substances |
US2721552A (en) | 1954-03-29 | 1955-10-25 | Nosik William Andre | Multiple chamber container |
FR1528920A (en) * | 1967-05-05 | 1968-06-14 | Multi-capacity cartridge for conditioning pre-dosed substances | |
AT318132B (en) | 1969-08-01 | 1974-09-25 | Dentaire Ivoclar Ets | Mixing container for holding substances that react with one another for the production of ready-to-use paste-like dental preparations |
DE1939315B2 (en) | 1969-08-01 | 1973-03-15 | Etablissement Dentaire Ivoclar, Schaan (Liechtenstein) | MULTI-CHAMBER CONTAINER FOR THE ACCOMMODATION OF REACTIVE SUBSTANCES FOR THE PRODUCTION OF READY-TO-USE DENTAL PREPARATIONS |
BE759385A (en) * | 1970-01-17 | 1971-04-30 | Vetreria F Lli Benecchi Di Ben | MEDICINAL BOTTLE PROVIDED WITH A METAL RETAINING CAPSULE TEARABLE AND A CAP WITH BOTTOM TEARABLE BY A BREAKING SLEEVE |
US3762542A (en) | 1971-11-24 | 1973-10-02 | Questor Corp | Infant feeding means |
US3924741A (en) * | 1975-03-04 | 1975-12-09 | Gibson Ass Inc | Two-compartment container |
FR2342914A1 (en) | 1976-03-02 | 1977-09-30 | Oreal | PACKAGING DEVICE FOR TWO INSULATED PRODUCTS ONE OF THE OTHER BEFORE DISTRIBUTION |
IL52695A (en) | 1977-08-10 | 1979-11-30 | Silmet Ltd | Mixing capsule |
US4707966A (en) | 1981-08-26 | 1987-11-24 | Automatic Liquid Packaging, Inc. | Container with an encapsulated top insert and method and apparatus for making same |
US4596110A (en) | 1981-08-26 | 1986-06-24 | Automatic Liquid Packaging, Inc. | Container with insert having a fully or partially encapsulating seal with a frangible web formed against said insert |
FR2564433B1 (en) | 1984-05-15 | 1986-10-03 | Oreal | CONTAINER FOR PACKAGING AND DISPENSING A LIQUID PRODUCT AND AT LEAST ONE SEPARATE ADDITIONAL PRODUCT DURING STORAGE |
IT1185850B (en) * | 1985-08-02 | 1987-11-18 | Zambon Spa | DROP TANK CAP FOR BOTTLES |
US4903865A (en) | 1988-09-19 | 1990-02-27 | Janowitz C Michael | Push button cap containing an additive for containers |
JP3146465B2 (en) | 1992-03-13 | 2001-03-19 | 株式会社ニッショー | Chemical injection device |
US5649637A (en) * | 1994-06-02 | 1997-07-22 | Automatic Liquid Packaging, Inc. | Torque-resistant closure for a hermetically sealed container |
FR2722765B1 (en) * | 1994-07-25 | 1996-08-23 | Oreal | CONTAINER ALLOWING THE STORAGE OF AT LEAST TWO PRODUCTS, THE MIXTURE OF THESE PRODUCTS AND THE DISTRIBUTION OF THE MIXTURE THUS OBTAINED |
DE69602949T2 (en) * | 1995-07-29 | 2000-02-17 | Rocep-Lusol Holdings Ltd., Renfrew | METHOD FOR MIXING A FLUID WITH A LIQUID |
US5711420A (en) | 1996-02-20 | 1998-01-27 | Canning Concepts, Inc. | Apparatus for dispensing a substance in a liquid beverage |
US5772017A (en) | 1996-10-25 | 1998-06-30 | Kang; Heung Sun | Beverage mixing dispenser device |
IT1292677B1 (en) * | 1997-02-28 | 1999-02-11 | Bormioli Metalplast Spa | PACKAGING TO KEEP THE PRODUCTS SEPARATE BEFORE USE. |
ES2221159T3 (en) * | 1997-03-12 | 2004-12-16 | Fredrick Coory | DOWNLOAD CAPERUTA WITH DISPOSABLE BASKET CONTAINING TABLETS. |
FR2765861B1 (en) * | 1997-07-08 | 1999-09-24 | Oreal | DEVICE FOR THE SEPARATE PACKAGING OF TWO COMPONENTS AND MANUFACTURING PROCESS |
US5927549A (en) * | 1998-03-20 | 1999-07-27 | Aptargroup, Inc. | Dispensing structure with frangible membrane for separating two products |
DE19812657A1 (en) * | 1998-03-23 | 1998-12-24 | Wella Ag | Two-component container for the temporary storage of peroxide and hair dye |
US5950819A (en) | 1998-05-08 | 1999-09-14 | Sellars; Andy | Storage, admixing, and dispensing system |
US6003728A (en) * | 1998-10-22 | 1999-12-21 | Aptargroup, Inc. | Dispensing structure with an openable member for separating two products |
US6152296A (en) * | 1998-11-06 | 2000-11-28 | Shih; Kuang-Sheng | Additive holder for a pet bottle |
FR2789372B1 (en) * | 1999-02-10 | 2001-04-13 | Oreal | DEVICE FOR STORING THREE COMPONENTS, THEIR MIXTURE AND THE DISPENSING OF THE MIXTURE THUS OBTAINED |
AU6066799A (en) * | 1999-11-26 | 2001-05-31 | Lily Hsu | Container device for separately enclosing two different substances |
-
2000
- 2000-12-06 US US09/731,128 patent/US6387073B1/en not_active Expired - Lifetime
-
2001
- 2001-12-04 CA CA002430715A patent/CA2430715C/en not_active Expired - Lifetime
- 2001-12-04 EP EP01989899A patent/EP1345647B1/en not_active Expired - Lifetime
- 2001-12-04 WO PCT/US2001/046384 patent/WO2002045789A1/en active Application Filing
- 2001-12-04 MX MXPA03005089A patent/MXPA03005089A/en active IP Right Grant
- 2001-12-04 JP JP2002547569A patent/JP2004515279A/en active Pending
- 2001-12-04 DE DE60139637T patent/DE60139637D1/en not_active Expired - Lifetime
- 2001-12-04 AT AT01989899T patent/ATE439824T1/en not_active IP Right Cessation
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060057257A1 (en) * | 2003-10-27 | 2006-03-16 | Ma Mike X | Twist-open closure having inclined frangible membrane |
US7337921B2 (en) | 2003-10-27 | 2008-03-04 | Portola Packaging, Inc. | Twist-open closure having inclined frangible membrane |
US20070262045A1 (en) * | 2004-11-08 | 2007-11-15 | Bernd Hansen | Container, in Particular an Ampoule |
US8087524B2 (en) * | 2004-11-08 | 2012-01-03 | Bernd Hansen | Container, in particular an ampoule |
US20060108314A1 (en) * | 2004-11-23 | 2006-05-25 | Cho Young K | Sanitary double cap allowing addition of adjunct to contents of a container |
US7748550B2 (en) * | 2004-11-23 | 2010-07-06 | Young Kook Cho | Sanitary double cap allowing addition of adjunct to contents of a container |
US20110054437A1 (en) * | 2008-04-17 | 2011-03-03 | Philippe Perovitch | Device for conserving, extemporaneously preparing, and administering an active principle |
US8870844B2 (en) * | 2008-04-17 | 2014-10-28 | Philippe Perovitch | Device for conserving, extemporaneously preparing, and administering an active principle |
US20110000800A1 (en) * | 2009-02-11 | 2011-01-06 | Robert Dale Rohr | Inverted dome to supply dose |
US8490786B2 (en) * | 2009-02-11 | 2013-07-23 | Liquid Health Labs, Inc. | Inverted dome to supply dose |
US10293993B2 (en) | 2009-11-05 | 2019-05-21 | Liquid Health Labs, Inc. | Universal domed closure to supply dose |
WO2012052853A3 (en) * | 2010-10-21 | 2012-11-01 | Aptalis Pharma Limited | Oral dosing device for administration of medication |
KR101403015B1 (en) | 2012-02-29 | 2014-06-03 | 주식회사태준제약 | Dispensing container |
Also Published As
Publication number | Publication date |
---|---|
MXPA03005089A (en) | 2004-10-15 |
JP2004515279A (en) | 2004-05-27 |
CA2430715A1 (en) | 2002-06-13 |
EP1345647B1 (en) | 2009-08-19 |
ATE439824T1 (en) | 2009-09-15 |
CA2430715C (en) | 2010-03-09 |
WO2002045789A1 (en) | 2002-06-13 |
DE60139637D1 (en) | 2009-10-01 |
US6387073B1 (en) | 2002-05-14 |
EP1345647A1 (en) | 2003-09-24 |
EP1345647A4 (en) | 2007-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6387073B1 (en) | Hermetically sealed container with medicament storing and dispensing insert | |
US8215481B1 (en) | Container closure for retaining an additive material | |
US7870952B2 (en) | Packaging the extemporaneous products, particularly medicinal, pharmaceutical, cosmetic products or the like | |
US8151985B2 (en) | Containers for storing at least two substances for subsequent mixing | |
JP2602614B2 (en) | Chemical container | |
US4950237A (en) | Dual chambered mixing and dispensing vial | |
US3220588A (en) | Compartmental dispensing receptacle with accessories | |
US6571971B1 (en) | Hermetically sealed container with pierceable entry port | |
HU223435B1 (en) | Container with a sealed insert, and pump for opening said sealing | |
JP2000513307A (en) | Cap having a blister pack that breaks with opening of the cap | |
US20100116699A1 (en) | Supplement compartment for beverage container | |
US20120216909A1 (en) | Dosing Adapter for Use with Oral Syringe | |
US9975683B2 (en) | Cap with additive chamber and associated packaging unit | |
US4073406A (en) | Container for storing two products separately and dispensing a mixture thereof | |
EP0542295B1 (en) | Drug vessel | |
US4470505A (en) | Method and apparatus for storing, mixing and delivering dental amalgam | |
WO2002051711A1 (en) | An improved closure, capsule and dispensing system | |
AU700814B2 (en) | Container-closure assembly | |
EP3659938B1 (en) | Closure device for a bottle adapted for storing a substance contained in a cavity thereof | |
CN103171821A (en) | Bottle capable of storing solid material | |
CA2065814A1 (en) | Dispenser device | |
EP0562943A1 (en) | Double chambered package | |
CN203158468U (en) | Bottle used for storage of solid materials | |
JP2023114600A (en) | Cap having virgin seal function and attachable to container mouth by screwing-in | |
EP1278684A1 (en) | Container for mixing two components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AUTOMATIC LIQUID PACKAGING, INC., ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LEO, FRANK N.;REEL/FRAME:011735/0390 Effective date: 20010316 Owner name: WEILER ENGINEERING, INC., ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WEILER, GERHARD H.;REEL/FRAME:011738/0186 Effective date: 20010315 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: MORGAN STANLEY SENIOR FUNDING, INC.,NEW YORK Free format text: SECURITY AGREEMENT;ASSIGNORS:PTS ACQUISITION CORP.;PTS INTERMEDIATE HOLDINGS LLC;CARDINAL HEALTH 400, INC.;AND OTHERS;REEL/FRAME:019323/0302 Effective date: 20070410 Owner name: MORGAN STANLEY SENIOR FUNDING, INC., NEW YORK Free format text: SECURITY AGREEMENT;ASSIGNORS:PTS ACQUISITION CORP.;PTS INTERMEDIATE HOLDINGS LLC;CARDINAL HEALTH 400, INC.;AND OTHERS;REEL/FRAME:019323/0302 Effective date: 20070410 |
|
AS | Assignment |
Owner name: CATALENT USA WOODSTOCK, INC., NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 Owner name: CATALENT USA PACKAGING, LLC, NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 Owner name: CATALENT PHARMA SOLUTIONS, INC., NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 Owner name: CATALENT USA PAINTBALL, INC., NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 Owner name: CATALENT PHARMA SOLUTIONS, LLC, NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 Owner name: CATALENT USA WOODSTOCK, INC.,NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 Owner name: CATALENT USA PACKAGING, LLC,NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 Owner name: CATALENT PHARMA SOLUTIONS, INC.,NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 Owner name: CATALENT USA PAINTBALL, INC.,NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 Owner name: CATALENT PHARMA SOLUTIONS, LLC,NEW JERSEY Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622 Effective date: 20070619 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |
|
AS | Assignment |
Owner name: CATALENT USA WOODSTOCK, INC. (FORMERLY KNOWN AS CARDINAL HEALTH 400, INC.), NEW JERSEY Free format text: PARTIAL RELEASE OF SECURITY INTEREST;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:055681/0049 Effective date: 20210322 Owner name: CATALENT PHARMA SOLUTIONS, LLC, NEW JERSEY Free format text: PARTIAL RELEASE OF SECURITY INTEREST;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:055681/0049 Effective date: 20210322 Owner name: R.P. SCHERER TECHNOLOGIES, LLC (F/K/A R.P. SCHERER TECHNOLOGIES, INC.), NEW JERSEY Free format text: PARTIAL RELEASE OF SECURITY INTEREST;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:055681/0049 Effective date: 20210322 |